Quidel, the San Diego-based maker of diagnostic tests, said today it has hired Douglas Bryant as CEO. Bryant, 51, was chief operating officer of Luminex, where he oversaw its molecular diagnostics business. He will start with a minimum base salary of $450,000, plus an annual bonus worth 80 percent to 120 percent of his salary, depending on whether he reaches goals set by the board. Bryant officially replaces Caren Mason on March 1.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
